Long-term use of ticagrelor in patients with prior myocardial infarction (2015)
- Authors:
- Bonaca, Marc P.
- Bhatt, Deepak L.
- Cohen, Marc
- Steg, Philippe Gabriel
- Storey, Robert F.
- Jensen, Eva C.
- Magnani, Giulia
- Bansilal, Sameer
- Fish, M. Polly
- Im, Kyungah
- Bengtsson, Olof
- Ophuis, Ton Oude
- Budaj, Andrzej
- Theroux, Pierre
- Ruda, Mikhail
- Hamm, Christian
- Goto, Shinya
- Spinar, Jindrich
- Nicolau, José Carlos
- Kiss, Robert G.
- Murphy, Sabina A.
- Wiviott, Stephen D.
- Held, Peter
- Braunwald, Eugene
- Sabatine, Marc S.
- Marin Neto, José Antonio
- USP affiliated authors: NICOLAU, JOSÉ CARLOS - FM ; MARIN NETO, JOSE ANTONIO - FMRP
- Unidades: FM; FMRP
- DOI: 10.1056/NEJMoa1500857
- Subjects: FATORES DE RISCO; INFARTO DO MIOCÁRDIO; ADESÃO À MEDICAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: The New England Journal of Medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 372, n. 19, 1791-1800, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
BONACA, Marc P. et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, v. 372, n. 19, 2015Tradução . . Disponível em: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260. Acesso em: 09 jan. 2026. -
APA
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., et al. (2015). Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, 372( 19). doi:10.1056/NEJMoa1500857 -
NLM
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2026 jan. 09 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260 -
Vancouver
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):[citado 2026 jan. 09 ] Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260 - Resumo Executivo: Diretrizes da SBC sobre Angina Instável e Infarto Agudo do Miocárdio Sem Supradesnível do Segmento ST
- Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
- Vorapaxar in the secondary prevention of atherothrombotic events
- Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021
- Oclusão de comunicação interventricular pós-infarto com prótese percutânea CERA
- Spontaneous MI After Non–ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS Trial
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- Timing, Profile, and Predictors of Spontaneous Myocardial Infarction Following a Non-ST-Segment Elevation Acute Coronary Syndrome Event: Insights From the TRILOGY-ACS Trial
- The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial
- Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial
Informações sobre o DOI: 10.1056/NEJMoa1500857 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas